Differences in the reduced 18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease: correlations with the three main symptoms

Journal of the Neurological Sciences - Tập 136 Số 1-2 - Trang 169-173 - 1996
Makoto Otsuka1, Y Ichiya2, Yasuo Kuwabara2, Shinichi Hosokawa3, Masayuki Sasaki2, Tsuyoshi Yoshida2, Toshimitsu Fukumura2, Kouji Masuda2, Motohiro Kato4
1Department of Radiology, Medical Institute of Bioregulation, Kyushu University, 4546 Tsurumihara, Beppu 874, Japan
2Department of Radiology, Faculty of Medicine, Kyushu University, Fukuoka 812, Japan
3Department of Neurology, Faculty of Medicine, Kyushu University, Fukuoka 812 Japan
4Department of Clinical Neurophysiology, Faculty of Medicine, Kyushu University, Fukuoka 812 Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Bernheimer, 1973, Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations, J. Neurol. Sci., 20, 415, 10.1016/0022-510X(73)90175-5

Brooks, 1990, Differing patterns of striatal 18F-Dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy, Ann. Neurol., 28, 547, 10.1002/ana.410280412

Garnett, 1987, A rostrocaudal gradient for aromatic acid decarboxylase in the human striatum, Can. J. Neurol. Sci., 14, 444, 10.1017/S0317167100037884

Gibb, 1991, Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease, J. Neurol. Neurosurg. Psychiatry, 54, 388, 10.1136/jnnp.54.5.388

Goto, 1989, Subdivisional involvement of nigrostriatal loop in idiopathic Parkinson's disease and striatonigral degeneration, Ann. Neurol., 26, 766, 10.1002/ana.410260613

Hoehn, 1967, Parkinsonism: onset, progression and mortality, Neurology, 17, 427, 10.1212/WNL.17.5.427

Kanno, 1985, Design and evaluation of the positron emission tomograph: HEADTOME 3, J. Comput. Assist. Tomog., 9, 931, 10.1097/00004728-198509000-00017

Kish, 1988, Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathological and clinical implications, N. Engl. J. Med., 318, 876, 10.1056/NEJM198804073181402

Martin, 1986, Positron emission tomography in Parkinson's disease: glucose and dopa metabolism, Adv. Neurol., 45, 95

Nagasawa, 1993, 6-[18F]Fluorodopa metabolism in patients with hemiparkinsonism studied by positron emission tomography, J. Neurol. Sci., 115, 136, 10.1016/0022-510X(93)90216-L

Nahmias, 1985, Striatal dopamine distribution in Parkinsonian patients during life, J. Neurol. Sci., 69, 223, 10.1016/0022-510X(85)90135-2

Otsuka, 1989, Cerebral blood flow, oxygen and glucose metabolism with PET in progressive supranuclear palsy, Ann. Nucl. Med., 3, 111, 10.1007/BF03178296

Otsuka, 1991, Striatal blood flow, glucose metabolism and 18F-Dopa uptake: difference in Parkinson's disease and atypical Parkinsonism, J. Neurol. Neurosurg. Psychiatry, 54, 898, 10.1136/jnnp.54.10.898

Otsuka, 1993, Evaluation of the ratio method compared with graphical analyses for estimating nigrostriatal function in human 18F-dopa PET studies with or without carbidopa, Nucl. Med. Com., 14, 862, 10.1097/00006231-199310000-00005

Pifl, 1988, The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease, Neurosci. Lett., 92, 228, 10.1016/0304-3940(88)90066-3

Snow, 1993, Human positron emission tomographic [18F]Fluorodopa studies correlate with dopamine cell counts and levels, Ann. Neurol., 34, 324, 10.1002/ana.410340304